CNE000000BG1
CNE000000BG1
XINHUA PHARM
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q1 '26 31.03.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 10.32B EUR | 10.37B EUR |
Enterprise Value | 10.46B EUR | 10.51B EUR |
Valuation Multiples | ||
Trailing P/E | 47.77x | 30.37x |
Forward P/E | 18.28x | -- |
Price to Sales | 1.22x | 1.14x |
Price to Book | 1.96x | 1.94x |
EV/Revenue | 1.24x | 1.16x |
EV/EBITDA | 11.81x | 19.85x |
Price to FCF (P/FCF) | 22.08x | 48.64x |
EV/FCF | 22.39x | 49.32x |
FCF Yield | 4.53% | 2.06% |